Skye Peptides loads a homepage and then stops. The shop, the product pages and whatever certificates exist all sit behind a login, and the registration page states that “Skye reserves the right to refuse membership at its sole discretion”. A supplier that decides who may see its prices has, by design, made itself nearly impossible to verify from the outside. We went looking for whatever could be checked anyway, and this report is the result.
Our method was the same one we apply to every supplier. We read every page a visitor can reach without an account, which in this case meant the homepage, the terms and conditions and the registration form. We then searched the public record for a corporate filing, a warning letter, a review-site profile and independent test results. Where the only information came from a third party, we say so and attribute it, because none of it could be checked against a vendor document.
What the public pages claim
The public pages make very few claims, which is itself a finding. The homepage carries a research-use-only disclaimer and a statement that the products have not been evaluated by the FDA, both correctly worded. The terms and conditions identify the operator only as “Skye Research/Skye Peptides”, with no legal entity, no address and no governing jurisdiction. The only contact route is support@skyepeptides.com, and the email address on the terms page is obscured by Cloudflare so that it cannot be read without a script.
A shipping estimate of 3 to 5 business days domestic and 2 to 4 weeks international circulates in connection with the company, but it comes from a review at peptidedossier.com, not from the vendor. We record the company as shipping from the United States with international service, and we flag that both facts rest on a third party. Nothing on the vendor’s own pages states a carrier, a cutoff time, a payment method, a return window or a guarantee.
What we could confirm
The disclaimers exist and say what they should. The support address is published. The Trustpilot profile at trustpilot.com/review/skyepeptides.com is live, unclaimed by the company, and shows 3.8 from 50 reviews. That is the full list of things on the public side that held up, and it took one short paragraph to state.
We also confirmed one negative. No FDA warning letter naming Skye Peptides was found as of October 19, 2026. A letter dated December 2024 to Skye Biologics Holdings LLC concerns an unrelated company and should not be attached to this one, as it sometimes is in search results.
What fell apart, and what stayed hidden
The company’s identity is the first thing that fails. The record lists Los Angeles as the location, but Finnrick, an independent testing aggregator, reports that the address it found maps to a virtual-office or coworking provider, and that it could locate no California Secretary of State record and no OpenCorporates record for the business. The vendor publishes no name to check against those registers in any case. A company with no public legal name, no public address and no public filing has not shown that it exists as a company, whatever it may be selling.
The second failure is the certificate program, or rather its absence from view. Finnrick notes that public Janoshik or certificate pathways exist for some products and references Disclosed Labs, Janoshik and Peptigrity in its own certificate review. None of those labs is named anywhere a visitor to skyepeptides.com can see, so we attribute the information entirely to Finnrick and record public certificates as absent. Finnrick’s own sampling is the only test record available: 48 passes and 45 failures across 93 tests, a 57 percent rating, with BPC-157 passing 3 of 12. Finnrick’s program covered 12 products, including BPC-157, TB-500, GHK-Cu, Ipamorelin, Tesamorelin, CJC-1295 and several GLP-class items, and those names populate our record because Finnrick tested them, not because the vendor listed them where we could see. Finnrick prices BPC-157 at $5.90 per milligram; no vial price was observable on the site.
A third problem makes the first two worse. Finnrick reports at least five lookalike or impersonation domains using Skye naming. A buyer who reaches a Skye site through a search result has no public address, entity or certificate to compare against, so there is no way to tell the original from a copy, and a login wall on the genuine site looks exactly like a login wall on a counterfeit one. Everything commercial remains unverified: prices, product count, formats, labs, methods, carriers, turnaround, payment methods, returns, guarantees and founding year. The one specific testing claim we can place against the company is the one Finnrick made, and it is not a flattering one.
We want to be fair about what this does and does not mean. A gated storefront is not proof of bad faith, and some suppliers restrict access for reasons of their own. It does mean that the burden of proof has been shifted entirely onto the buyer, who must register, be approved and place an order before learning anything a reviewer could check. We do not think a research buyer should have to do that, and we do not think a company that chooses this model can complain when it is described as unverified.
Our read
Skye Peptides asks for an account before it will show a price and reserves the right to refuse one. What it leaves in public view is a disclaimer, an email address and a middling review profile. What third parties have found is a virtual office, no corporate filing, a cluster of lookalike domains and fewer than six in ten independent samples passing. We have no basis to call any claim verified, because almost no claims are made where they can be seen, and a buyer who needs to know who is behind an order before placing it will not find out here.
